Gainers

• SciSparc (NASDAQ:SPRC) shares moved upwards by 38.8% to $5.87 during Monday's after-market session. The market value of their outstanding shares is at $2.4 million.
• BridgeBio Oncology (NASDAQ:BBOT) stock rose 6.47% to $9.86. The company's market cap stands at $748.3 million.
• Artiva Biotherapeutics (NASDAQ:ARTV) shares moved upwards by 6.42% to $14.25. The company's market cap stands at $308.0 million.
• ALPS Group (NASDAQ:ALPS) shares rose 5.25% to $1.0. The market value of their outstanding shares is at $166.0 million.
• Streamex (NASDAQ:STEX) shares rose 4.82% to $1.12. The market value of their outstanding shares is at $101.5 million.
• GH Research (NASDAQ:GHRS) stock increased by 4.69% to $22.51. The company's market cap stands at $1.1 billion.

Losers

• Precipio (NASDAQ:PRPO) shares declined by 21.2% to $22.25 during Monday's after-market session. The market value of their outstanding shares is at $49.5 million.
• Spruce Biosciences (NASDAQ:SPRB) stock fell 12.73% to $61.0. The company's market cap stands at $96.4 million.
• Theriva Biologics (AMEX:TOVX) shares declined by 11.96% to $0.36. The market value of their outstanding shares is at $11.8 million.
• Psyence Biomedical (NASDAQ:PBM) shares fell 9.83% to $10.19. The market value of their outstanding shares is at $7.7 million.
• BNB Plus (NASDAQ:BNBX) stock decreased by 7.84% to $0.51. The company's market cap stands at $3.3 million.
• Akari Therapeutics (NASDAQ:AKTX) stock declined by 6.4% to $5.56. The market value of their outstanding shares is at $207.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.